The company said, “In conjunction with today’s announcement, Neuronetics (STIM) reaffirmed the financial guidance it provided during its fourth quarter 2025 earnings call on March 17, 2026.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STIM:
- Neuronetics’ largest independent shareholder urges review of alternatives
- Neuronetics price target lowered to $3 from $7 at Canaccord
- Neuronetics Earnings Call: Growth Momentum Meets Margin Strain
- Neuronetics files to sell 20.74M shares of common stock for holders
- Neuronetics Appoints New CEO to Lead Next Growth Phase